Ibu Atid

Ibuprofen, the active ingredient in Ibu Atid, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for systemic use. It is employed to relieve pain, reduce fever, and lessen inflammation in adults and children when appropriate. GNH USA supplies Ibu Atid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen acts systemically to modulate inflammatory pathways and is indicated for several common conditions. - Pain: provides analgesia for mild to moderate musculoskeletal, dental and postoperative pain. - Fever: lowers elevated body temperature associated with infections or inflammatory states. - Inflammation: reduces swelling and stiffness in conditions such as arthritis or soft‑tissue injury.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or mild abdominal pain. - Headache: transient tension‑type headache. - Dizziness: occasional light‑headedness. - Rash: mild skin erythema or pruritus. - Elevated blood pressure: modest rise in systolic/diastolic values.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: may present with melena or hematemesis. - Renal impairment: acute kidney injury especially in dehydrated patients. - Hepatotoxicity: elevated liver enzymes or jaundice. - Severe hypersensitivity: anaphylaxis, Stevens‑Johnson syndrome. - Cardiovascular events: increased risk of myocardial infarction or stroke with high‑dose or prolonged use.

Before initiating ibuprofen therapy, consider patient‑specific risk factors and monitor for adverse outcomes. - Renal function: assess baseline creatinine and avoid in severe renal impairment. - Gastrointestinal risk: avoid in patients with active ulcer disease or a history of GI bleeding. - Cardiovascular status: use caution in individuals with hypertension, heart failure, or coronary artery disease. - Concomitant medications: review for drugs that may increase bleeding risk or renal toxicity. - Pregnancy and lactation: consult a healthcare professional before use during pregnancy or breastfeeding. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Ibuprofen can alter the efficacy or safety profile of several co‑administered medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened risk of serious bleeding. - Selective COX‑2 inhibitors: additive gastrointestinal toxicity. - High‑dose aspirin: increased renal and GI adverse effects.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion, especially in volume‑depleted patients. - Diuretics: potential for reduced antihypertensive effect and renal impairment. - Lithium: ibuprofen can raise serum lithium levels, requiring monitoring.